Thrombolex, Inc. has been awarded a group purchasing agreement with Premier Inc., effective December 1, 2022. The new agreement allows Premier members, at.
Thrombolex Releases the Results of the RESCUE Pivotal Trial for the Treatment of Acute Pulmonary Embolism (PE) with the BASHIR™ Endovascular Catheter.
2021 OCT 29 By a News Reporter-Staff News Editor at Insurance Daily News - The blockage of lung arteries by a blood clot results in pulmonary embolism- a condition requiring emergency care that affects more than 300,000 people in the United States each year. Now, in a major step forward, researchers at the Lewis Katz School of Medicine at Temple University.
The BASHIR™ Endovascular Catheter (BEC) and the BASHIR™ Plus Endovascular Catheters (BASHIR™+ 10, BASHIR™+20, BASHIR™+30,.